University of Navarra (Spain) researchers have developed RNACOREX, a new open-source software capable of identifying gene ...

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today ...

University of Navarra (Spain) researchers have developed RNACOREX, a new open-source software capable of identifying gene regulation networks with applications in cancer survival analysis.

TripletDGC links disease genes→cell types→diseases via eQTL-scRNA integration, exposing sparse but critical cell drivers and potential comorbidity ...

Researchers have identified specific coupled patterns of brain activity and gene expression that help explain impulsive ...

Researchers have developed a novel approach to detect ALS and predict survival by measuring genetic activity in blood cells, a study found.

In December 2025, Castle Biosciences reported Nature Communications data from the largest prospective, multicenter uveal melanoma study showing that combining its DecisionDx-UM test with PRAME gene ...

Researchers in Beijing have generated a transcriptomic atlas comparing human fetal tooth germs from the upper and lower jaws at the critical cap stage of development. Previous studies of tooth ...

New data analysis clarifies misleading benchmarks released by a competitor; separate SkylineDx analysis demonstrates Merlin CP-GEP Test provides stronger metastatic-risk stratification and superior ...

The Global Gene Expression Market is estimated to be valued at USD 16.56 Bn in 2025 and is expected to reach USD 23.61 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.2% from 2025 to ...